Form 4: Opaleye Management Significantly Increases Stake in Codexis, Signaling Strong Confidence

Opaleye Management Inc., a 10% owner of Codexis, Inc., has substantially boosted its beneficial ownership of the company's common stock through recent open market purchases.

Summary

• Opaleye Management Inc., identified as a 10% owner of CODEXIS, INC. (CDXS), reported two recent acquisitions of the company's common stock.
• On May 23, 2025, Opaleye Management Inc. purchased 2,320,000 shares of Codexis common stock at a price of $2.36 per share.
• Subsequently, on May 28, 2025, an additional 5,000 shares were acquired at the same price of $2.36 per share.
• Following these transactions, Opaleye, L.P., which is managed by Opaleye Management Inc., beneficially owns 12,000,000 shares of Codexis common stock.
• An additional 250,000 shares are beneficially owned through a separately managed account, also under the management of Opaleye Management Inc.
• The total beneficial ownership reported by Opaleye Management Inc. across its managed entities now aggregates to 12,250,000 shares.

Sentiment

Score: 8

Explanation: The substantial insider buying by a 10% owner indicates strong confidence in the company's future, which is a highly positive signal for investors.

Positives

• A significant insider purchase by a 10% owner, Opaleye Management Inc., indicates strong confidence in Codexis's future prospects and valuation.
• The acquisition of 2,325,000 shares (2,320,000 + 5,000) at $2.36 per share represents a substantial financial commitment by a major shareholder.
• The increased beneficial ownership to 12,250,000 shares reinforces Opaleye Management Inc.'s long-term commitment to Codexis.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance, as it is a report of past transactions in beneficial ownership.

Industry Context

Insider buying, particularly by a significant shareholder like Opaleye Management Inc., often signals strong internal confidence in the company's strategic direction and future performance within its sector. This action suggests that the investor believes the current stock price may be undervalued relative to the company's intrinsic value or future potential, which could be a positive indicator for the broader biotechnology or enzyme engineering industry.

Stakeholder Impact

• Shareholders may interpret the significant insider buying as a positive indicator of future stock performance and management confidence.
• The increased stake by a major investor could potentially influence corporate governance and strategic decisions, aligning interests with long-term value creation.

Key Dates

Recommendation

Keywords

Codexis, CDXS, Opaleye Management, Insider Buying, Form 4, Beneficial Ownership, Stock Purchase, Biotechnology, Enzyme Engineering